Parloff, “Disruptive Diagnostics Firm Theranos Gets Boost from FDA,” Fortune, July 2, 2015.
Two months earlier, Balwani had terrorized: Anonymous review of Theranos posted on Glassdoor on May 11, 2015.
During the roundtable discussion: Theranos, “Theranos Hosts Vice President Biden for Summit on a New Era of Preventive Health Care,” press release, July 23, 2015, Theranos website.
He also praised Holmes: Ibid.
A few days later, on July 28, I opened: Elizabeth Holmes, “How to Usher in a New Era of Preventive Health Care,” Wall Street Journal, July 28, 2015.
23. DAMAGE CONTROL
In March, a month after: VC Experts report on Theranos Inc.
Of the more than $430 million: Christopher Weaver and John Carreyrou, “Theranos Offers Shares for Promise Not to Sue,” Wall Street Journal, March 23, 2017.
It was created by the Russian: Breakthrough Prize website; breakthroughprize.
Its cover letter stated: Letter written by Elizabeth Holmes to Rupert Murdoch on Theranos letterhead dated December 4, 2014.
The one call he placed: Theranos announced an alliance with the Cleveland Clinic on March 9, 2017, in a press release titled “Theranos and Cleveland Clinic Announce Strategic Alliance to Improve Patient Care Through Innovation in Laboratory Testing,” Theranos website.
The investment packet she sent: The projections were in a five-page document summarizing Theranos’s financial situation, including information about its capitalization, cash flow, and balance sheet. They were first disclosed in Christopher Weaver and John Carreyrou, “Theranos Foresaw Huge Growth in Revenue and Profits,” Wall Street Journal, December 5, 2016.
They included Cox Enterprises: Ibid.
By the time Mike Siconolfi and I: Altogether, Holmes had six meetings with Murdoch. They took place on November 26, 2014; April 22, 2015; July 3, 2015; September 29, 2015; January 30, 2016; and June 8, 2016. Two were in California and four in New York.
Boies Schiller’s Mike Brille: Letter from Michael A. Brille to Mary L. Symons, Rochelle Gibbons’s estate lawyer, dated August 5, 2015.
In a last-ditch effort to prevent: Letter from David Boies to Gerard Baker, copying Jason Conti, dated September 8, 2015.
The story was published on: John Carreyrou, “A Prized Startup’s Struggles,” Wall Street Journal, October 15, 2015.
The editor of Fortune: Fortune CEO Daily newsletter sent by Alan Murray to readers at 7:18 a.m. EST on October 15, 2015.
Forbes and The New Yorker: Matthew Herper, “Theranos’ Elizabeth Holmes Needs to Stop Complaining and Answer Questions,” Forbes, October 15, 2015; Eric Lach, “The Secrets of a Billionaire’s Blood-Testing Startup,” NewYorker, October 16, 2015.
One of them was former Netscape cofounder: Laura Arrillaga-Andreessen, “Five Visionary Tech Entrepreneurs Who Are Changing the World,” New York Times T Magazine, October 12, 2015.
In a press release it posted: Theranos, “Statement from Theranos,” press release, October 15, 2015, Theranos website.
Dressed in her usual all-black attire: Holmes’s October 15, 2015, interview with Jim Cramer on CNBC’s Mad Money program can be viewed on YouTube; youtube/​watch?v=rGfaJZAdfNE.
We quickly published my follow-up: John Carreyrou, “Hot Startup Theranos Dials Back Lab Tests at FDA’s Behest,” Wall Street Journal, October 16, 2015.
Theranos had issued a second: Theranos, “Statement from Theranos,” press release, October 16, 2015, Theranos website.
At his signal: Nick Bilton, “How Elizabeth Holmes’s House of Cards Came Tumbling Down,” Vanity Fair, September 6, 2016.
There was so much interest: Jonathan Krim’s October 21, 2016, interview of Holmes at the WSJ D.Live conference can be viewed on WSJ.
A few days earlier, Gassée: Jean-Louis Gassée, “Theranos Trouble: A First Person Account,” Monday Note, October 18, 2015.
Soon after the interview ended: Theranos, “Theranos Facts,” press release, October 21, 2015, Theranos website.
After Holmes’s appearance: Andrew Pollack, “Theranos, Facing Criticism, Says It Has Changed Board Structure,” New York Times, October 28, 2015.
Sure enough, within days: Letters from Heather King to William Lewis, CEO of Wall Street Journal parent company Dow Jones, copying Mark Jackson, Jason Conti, Gerard Baker, John Carreyrou, and Mike Siconolfi, dated November 4 and 5, 2015.
A third letter followed demanding: Letter from Heather King to Jason Conti dated November 11, 2015.
In an interview with Wired: Nick Stockton, “The Theranos Scandal Could Become a Legal Nightmare,” Wired, October 29, 2015.
They revealed that Walgreens: Michael Siconolfi, John Carreyrou, and Christopher Weaver, “Walgreens Scrutinizes Theranos Testing,” Wall Street Journal, October 23, 2015.
that Theranos had tried to sell: Rolfe Winkler and John Carreyrou, “Theranos Authorizes New Shares That Could Raise Valuation,” Wall Street Journal, October 28, 2015.
that its lab was operating without: John Carreyrou, “Theranos Searches for Director to Oversee Laboratory,” Wall Street Journal, November 5, 2015.
and that Safeway had walked away: John Carreyrou, “Safeway, Theranos Split After $350 Million Deal Fizzles,” Wall Street Journal, November 10, 2015.
With each new story: Letter from Heather